T. Rowe Price Associates’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $163K | Buy |
|
|||||
|
2022
Q4 | $226K | Buy |
|
|||||
|
2022
Q3 | $210K | Buy |
|
|||||
|
2022
Q2 | $173K | Buy |
|
|||||
|
2022
Q1 | $128K | Sell |
|
|||||
|
2021
Q4 | $81K | Hold |
|
|||||
|
2021
Q3 | $96K | Hold |
|
|||||
|
2021
Q2 | $82K | Hold |
|
|||||
|
2021
Q1 | $95K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $9.35M | Buy |
|